Clinical characteristics of the prospectively studied RYGB surgery patients (n=19)
| Age (years) | 49.7 (13.0) |
| Gender (F:M) | 16:3 |
| Preoperative HbA1c (mmol/mol) | 56.8 (14.3) |
| Postoperative HbA1c 12 months (mmol/mol) | 37.4 (5.7) |
| Height (m) | 1.64 (0.08) |
| Preoperative weight (kg) | 115.3 (25.3) |
| Weight 1 month (kg) | 105.5 (24.2) |
| Weight loss 1 month (%) | 8.7% (2.6%) |
| Weight 3 months (kg) | 96.7 (21.1) |
| Weight loss 3 months (%) | 17.2% (3.5%) |
| Weight 12 months (kg) | 80.6 (16.3) |
| Weight loss 12 months (%) | 29.5% (7.3%) |
Mean (SD) shown.
RYGB, Roux-en-Y gastric bypass.